Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of non-alcoholic fatty liver disease
Drug Metabolism and Disposition, 08/04/09
Fisher CD et al. – These results suggest that significant and novel changes occur in hepatic CYP activity during progressive stages of NAFLD.
Related Articles
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 71%
Drinking Coffee Slows Progression Of Liver Disease In Chronic Hepatitis C Sufferers
ScienceDaily, 10/26/09
Relevance Score: 70%
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
EurekAlert, 10/21/09
Relevance Score: 70%
Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09
Relevance Score: 70%
Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557
Antimicrobial Agents and Chemotherapy, 11/05/09
Relevance Score: 69%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II
Clinical Pharmacokinetics, 12/01/09
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
British Journal of Clinical Pharmacology, 11/30/09
A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of free radicals in liver diseases
Hepatology International, 12/02/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


